Rachael Easton
Direttore Finanziario/CFO presso GLADSTONE INVESTMENT CORPORATION
Profilo
Rachael Easton is currently the Chief Financial Officer & Treasurer at Gladstone Investment Corp.
and the Vice President & Head-Clinical Development at Cogent Biosciences, Inc. She previously worked as the Sr. Medical Director-Oncology Clinical Development at GSK Plc.
Easton received her undergraduate degree from Washington & Lee University and her doctorate from Washington University School of Medicine.
Posizioni attive di Rachael Easton
| Società | Posizione | Inizio |
|---|---|---|
| COGENT BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 28/11/2022 |
| GLADSTONE INVESTMENT CORPORATION | Direttore Finanziario/CFO | 01/12/2021 |
Precedenti posizioni note di Rachael Easton
| Società | Posizione | Fine |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
Formazione di Rachael Easton
| Washington University School of Medicine | Doctorate Degree |
| Washington & Lee University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| COGENT BIOSCIENCES, INC. | Health Technology |
| GSK PLC | Health Technology |
| Aziende private | 1 |
|---|---|
Gladstone Investment Corp.
 Gladstone Investment Corp. Investment ManagersFinance Gladstone Investment Corp., a traded business development company invests in lower middle market companies located in the United States. The fund focuses on companies with an EBITDA of $3 to $20 million. It targets companies operating in the fields of manufacturing, consumer products and business and consumer services. It provides financing for debt, buyout and growth stage capital requirements with an investment size up to $75 million.. | Finance |
- Borsa valori
- Insiders
- Rachael Easton
